ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/01/26 | 2,761 | 2,773 | 2,749 | 2,760 | +7 | +0.3% | 138,700 |
2023/01/25 | 2,750 | 2,762 | 2,737 | 2,753 | +3 | +0.1% | 140,500 |
2023/01/24 | 2,732 | 2,750 | 2,722 | 2,750 | +22 | +0.8% | 164,100 |
2023/01/23 | 2,718 | 2,732 | 2,697 | 2,728 | +26 | +1% | 179,500 |
2023/01/20 | 2,715 | 2,715 | 2,689 | 2,702 | -1 | ±0% | 138,900 |
2023/01/19 | 2,690 | 2,706 | 2,677 | 2,703 | -12 | -0.4% | 160,900 |
2023/01/18 | 2,689 | 2,728 | 2,687 | 2,715 | +30 | +1.1% | 160,400 |
2023/01/17 | 2,701 | 2,713 | 2,670 | 2,685 | -16 | -0.6% | 134,600 |
2023/01/16 | 2,689 | 2,720 | 2,682 | 2,701 | +7 | +0.3% | 113,400 |
2023/01/13 | 2,695 | 2,716 | 2,690 | 2,694 | -16 | -0.6% | 203,900 |
2023/01/12 | 2,725 | 2,731 | 2,701 | 2,710 | +3 | +0.1% | 175,000 |
2023/01/11 | 2,730 | 2,740 | 2,705 | 2,707 | +1 | ±0% | 142,200 |
2023/01/10 | 2,739 | 2,752 | 2,706 | 2,706 | -39 | -1.4% | 160,500 |
2023/01/06 | 2,752 | 2,772 | 2,738 | 2,745 | -34 | -1.2% | 181,900 |
2023/01/05 | 2,812 | 2,812 | 2,778 | 2,779 | -41 | -1.5% | 155,300 |
2023/01/04 | 2,870 | 2,885 | 2,814 | 2,820 | -78 | -2.7% | 201,000 |
2022/12/30 | 2,918 | 2,928 | 2,898 | 2,898 | -17 | -0.6% | 120,700 |
2022/12/29 | 2,877 | 2,915 | 2,853 | 2,915 | +34 | +1.2% | 134,600 |
2022/12/28 | 2,882 | 2,895 | 2,865 | 2,881 | -9 | -0.3% | 110,000 |
2022/12/27 | 2,908 | 2,924 | 2,890 | 2,890 | -11 | -0.4% | 95,200 |
2022/12/26 | 2,941 | 2,941 | 2,901 | 2,901 | -29 | -1% | 81,900 |
2022/12/23 | 2,929 | 2,938 | 2,911 | 2,930 | -17 | -0.6% | 97,000 |
2022/12/22 | 2,957 | 2,957 | 2,918 | 2,947 | -11 | -0.4% | 149,700 |
2022/12/21 | 2,942 | 2,985 | 2,931 | 2,958 | -2 | -0.1% | 124,400 |
2022/12/20 | 3,020 | 3,025 | 2,930 | 2,960 | -50 | -1.7% | 151,100 |
2022/12/19 | 2,980 | 3,020 | 2,975 | 3,010 | ±0 | ±0% | 148,000 |
2022/12/16 | 3,000 | 3,040 | 2,985 | 3,010 | ±0 | ±0% | 231,300 |
2022/12/15 | 2,999 | 3,035 | 2,990 | 3,010 | +5 | +0.2% | 84,300 |
2022/12/14 | 2,998 | 3,015 | 2,985 | 3,005 | +27 | +0.9% | 118,100 |
2022/12/13 | 2,979 | 2,990 | 2,971 | 2,978 | +14 | +0.5% | 149,900 |
2022/12/12 | 2,960 | 3,000 | 2,949 | 2,964 | -2 | -0.1% | 212,400 |
2022/12/09 | 2,930 | 2,974 | 2,922 | 2,966 | +10 | +0.3% | 152,700 |
2022/12/08 | 2,952 | 2,964 | 2,934 | 2,956 | +17 | +0.6% | 112,900 |
2022/12/07 | 2,920 | 2,954 | 2,910 | 2,939 | -8 | -0.3% | 109,900 |
2022/12/06 | 2,927 | 2,947 | 2,918 | 2,947 | +5 | +0.2% | 132,000 |
2022/12/05 | 2,980 | 2,991 | 2,919 | 2,942 | +12 | +0.4% | 250,400 |
2022/12/02 | 2,965 | 2,965 | 2,912 | 2,930 | -68 | -2.3% | 210,600 |
2022/12/01 | 3,030 | 3,030 | 2,984 | 2,998 | -1 | ±0% | 107,400 |
2022/11/30 | 3,035 | 3,035 | 2,993 | 2,999 | -26 | -0.9% | 141,000 |
2022/11/29 | 3,040 | 3,040 | 3,005 | 3,025 | -35 | -1.1% | 76,400 |
2022/11/28 | 3,090 | 3,100 | 3,050 | 3,060 | -15 | -0.5% | 115,500 |
2022/11/25 | 3,085 | 3,090 | 3,055 | 3,075 | +15 | +0.5% | 92,300 |
2022/11/24 | 3,045 | 3,080 | 3,045 | 3,060 | +15 | +0.5% | 101,000 |
2022/11/22 | 3,000 | 3,060 | 3,000 | 3,045 | +58 | +1.9% | 144,900 |
2022/11/21 | 2,965 | 2,992 | 2,958 | 2,987 | +30 | +1% | 112,000 |
2022/11/18 | 2,960 | 2,968 | 2,947 | 2,957 | +9 | +0.3% | 117,800 |
2022/11/17 | 2,903 | 2,959 | 2,902 | 2,948 | +31 | +1.1% | 104,800 |
2022/11/16 | 2,910 | 2,922 | 2,890 | 2,917 | +3 | +0.1% | 90,500 |
2022/11/15 | 2,934 | 2,950 | 2,913 | 2,914 | -19 | -0.6% | 111,400 |
2022/11/14 | 2,965 | 2,970 | 2,921 | 2,933 | -33 | -1.1% | 116,200 |
451~
500
件表示中 / 3587件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 475,100円 | +22.6% | +68.1% | 2.86% | 12.66倍 | 1.23倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
参天薬 | 167,100円 | 0.0% | +50.6% | 2.03% | 17.81倍 | 2.00倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
ペプチド | 280,900円 | +56.7% | +357.2% | 0.00% | 26.01倍 | 6.20倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
久光薬 | 428,000円 | +7.3% | -3.8% | 2.10% | 19.87倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
日本新薬 | 411,300円 | +5.9% | 0.0% | 3.01% | 9.24倍 | 1.18倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム